Risk factors for Clostridium difficile toxin-positive nosocomial diarrhoea

International Journal of Antimicrobial Agents

Volumn 28, Issue 3, 2006, Pages 231-237

  Raveh, David ^a   Rabinowitz, Bella ^b   Breuer, Gabriel S ^a   Rudensky, Bernard ^a   Yinnon, Amos M ^a,b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Antibiotic associated colitis; Clostridium difficile; Diarrhoea; Nosocomial infections; Pseudomembranous colitis

Indexed keywords

CLINDAMYCIN; CLOSTRIDIUM DIFFICILE TOXIN A; DIURETIC AGENT; MACROLIDE; SERUM ALBUMIN;

ADULT; AGE; AGED; ARTICLE; DIARRHEA; FECES; FEMALE; HOSPITAL INFECTION; HUMAN; INTESTINE MOTILITY; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTIVARIATE ANALYSIS; NURSING HOME; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL MODEL; UREA NITROGEN BLOOD LEVEL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL TOXINS; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DIARRHEA; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; FEMALE; HOSPITALS; HUMANS; INFANT; MALE; MIDDLE AGED; NURSING HOMES; PREGNANCY; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 33747148395     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2006.04.013     Document Type: Article

References (25)

1. Thielman N.M., and Wilson K.M. Antibiotic-associated colitis. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Principles and practice of infectious diseases. 6th ed. (2005), Churchill Livingstone, Philadelphia, PA 1249-1263
2. Klingler P.J., Metzger P.P., Seelig H.S., Pettit P.D., Knudsen J.M., and Alvarez S.A. Clostridium difficile infection: risk factors, medical and surgical management. Dig Dis 18 (2000) 147-160
3. Tonna I., and Welsby P.D. Pathogenesis and treatment of Clostridium difficile infection. Postgrad Med J 81 (2005) 367-369
4. Hogenauer C., Hammer H.F., Krejs G.J., and Reisinger E.C. Mechanisms and management of antibiotic-associated diarrhea. Clin Infect Dis 27 (1998) 702-710
5. Wilcox M.H. Gastrointestinal disorders and the critically ill. Clostridium difficile infection and pseudomembranous colitis. Best Pract Res Clin Gastroenterol 17 (2003) 475-493
6. McFarland L.V., Mulligan M.E., Kwok R.Y., and Stamm W.E. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 320 (1989) 204-210
7. McFarland L.V., and Stamm W.E. Review of Clostridium difficile-associated diseases. Am J Infect Control 14 (1986) 99-109
8. Wistrom J., Norrby S.R., Myrhe E.B., et al. Frequency of antibiotic-associated diarrhoea in 2642 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother 47 (2001) 43-50
9. Gross M.H. Management of antibiotic-associated pseudomembranous colitis. Clin Pharm 4 (1985) 304-310
10. Noren T., Akerlund T., Back E., et al. Molecular epidemiology of hospital-associated and community-acquired Clostridium difficile infection in a Swedish county. J Clin Microbiol 42 (2004) 3635-3643
11. Anand A., and Glatt A.E. Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clin Infect Dis 17 (1993) 109-113
12. Chang V.T., and Nelson K. The role of physical proximity in nosocomial diarrhea. Clin Infect Dis 31 (2000) 717-722
13. Bulusu M., Narayan S., Shetler K., and Triadafilopoulos G. Leukocytosis as a harbinger and surrogate marker of Clostridium difficile infection in hospitalized patients with diarrhea. Am J Gastroenterol 95 (2000) 3137-3141
14. Jacobs J., Rudensky B., Dresner J., et al. Comparison of four laboratory tests for diagnosis of Clostridium difficile-associated diarrhea. Eur J Clin Microbiol Infect Dis 15 (1996) 561-566
15. Arfons L., Ray A.J., and Donskey C.J. Clostridium difficile infection among health care workers receiving antibiotic therapy. Clin Infect Dis 40 (2005) 1384-1385
16. Muto C.A., Pokrywka M., Shutt K., et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 26 (2005) 273-280
17. Katikireddi V. UK launches inquiry into Clostridium difficile outbreak. Can Med Assoc J 173 (2005) 138
18. Gaynes R., Rimland D., Killum E., et al. Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. Clin Infect Dis 38 (2004) 640-645
19. Baines S.D., Freeman J., and Wilcox M.H.J. Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model. J Antimicrob Chemother 55 (2005) 974-982
20. Schwaber M.J., Simhon A., Block C., Roval V., Ferderber N., and Shapiro M. Factors associated with nosocomial diarrhea and Clostridium difficile-associated disease on the adult wards of an urban tertiary care hospital. Eur J Clin Microbiol Infect Dis 19 (2000) 9-15
21. Martirosian G., Szczesny A., Cohen S.H., and Silva Jr. J. Analysis of Clostridium difficile-associated diarrhea among patients hospitalized in tertiary care academic hospital. Diagn Microbiol Infect Dis 52 (2005) 153-155
22. Zabel L.T., and Worm S. Linezolid contributed to Clostridium difficile colitis with fatal outcome. Infection 33 (2005) 155-157
23. Bouza E., Munoz P., and Alonso R. Clinical manifestations, treatment and control of infections caused by Clostridium difficile. Clin Microbiol Infect 11 Suppl. 4 (2005) 57-64
24. Wilkins T.D., and Lyerly D.M. Clostridium difficile testing: after 20 years, still challenging. J Clin Microbiol 41 (2003) 531-534
25. Zuckerman E., Kanel G., Ha C., Kahn J., Gottesman B.S., and Korula J. Low albumin gradient ascites complicating severe pseudomembranous colitis. Gastroenterology 112 (1997) 991-994